APA (7th ed.) Citation

Froessl, L. J., Saxon-Filipe, S., Rambally, S., & Syed, S. (2025). Effective treatment of early triple-negative breast cancer in a patient with sickle cell disease through chemotherapy and immune checkpoint inhibitor therapy: The keynote 522 regimen. Current problems in cancer. Case reports, 20, 100393. https://doi.org/10.1016/j.cpccr.2025.100393

Chicago Style (17th ed.) Citation

Froessl, Luise Josefine, Stevany Saxon-Filipe, Siayareh Rambally, and Samira Syed. "Effective Treatment of Early Triple-negative Breast Cancer in a Patient with Sickle Cell Disease Through Chemotherapy and Immune Checkpoint Inhibitor Therapy: The Keynote 522 Regimen." Current Problems in Cancer. Case Reports 20 (2025): 100393. https://doi.org/10.1016/j.cpccr.2025.100393.

MLA (9th ed.) Citation

Froessl, Luise Josefine, et al. "Effective Treatment of Early Triple-negative Breast Cancer in a Patient with Sickle Cell Disease Through Chemotherapy and Immune Checkpoint Inhibitor Therapy: The Keynote 522 Regimen." Current Problems in Cancer. Case Reports, vol. 20, 2025, p. 100393, https://doi.org/10.1016/j.cpccr.2025.100393.